Last reviewed · How we verify
NCT04577625
Effect of Probiotics on Testosterone in Men
NA trial testing Lactobacillus reuteri (L. reuteri) in Healthy in 60 participants. Completed in 5 June 2021.
5 June 2021
Quick facts
| Lead sponsor | BioGaia AB |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 5 November 2020 |
| Primary completion | 5 June 2021 |
| Estimated completion | 5 June 2021 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Lactobacillus reuteri (L. reuteri)
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
BioGaia AB — full company profile →
Who can join
Adults 50 to 65, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effect of L. reuteri ATCC PTA 6475 supplementation on testosterone in men.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus.
Huang S, Li F, Quan C, Jin D. · · 2024 · cited 8× · PMID 39520706 · DOI 10.1080/19490976.2024.2423024
Verify or expand the search:
- PubMed search for NCT04577625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other BioGaia AB trials
Trials by the same sponsor.
- NCT07190859 — Evaluating the Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With C · NA · recruiting
- NCT06462651 — Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic · NA · completed
- NCT05512234 — Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic · NA · recruiting
- NCT05044949 — Study Evaluating the Safety and Tolerability of a Probioitc · NA · completed
- NCT04692506 — Study Evaluating the Safety and Tolerability · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04577625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BioGaia AB
- Last refreshed: 21 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04577625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing